Usman Malik

Usman Malik is an accomplished business manager in sales and marketing, currently leading a team at Getz Pharma since July 2019, focusing on heart failure, hypertension, and diabetes. Usman has a proven track record, having launched Diampa LT, achieving a notable 40% market share in its category by March 2023, and previously led the launch of Savesto, securing a 56.7% market share in January 2021. Prior experience includes roles at Novo Nordisk, specializing in modern insulin brands, and significant positions at Getz Pharma, Highnoon Laboratories, CCL Pharmaceuticals, Windsor Pine Ltd UK, and Pfizer, demonstrating expertise across various therapeutic areas. Usman holds an MBA in Marketing from Coventry University and a Doctor of Pharmacy from Baqai Medical University.